Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 2/2013

Ausgabe 2/2013

Inhaltsverzeichnis ( 17 Artikel )

01.02.2013 | Review | Ausgabe 2/2013

Chemoimmunotherapy: reengineering tumor immunity

Gang Chen, Leisha A. Emens

01.02.2013 | Perspectives | Ausgabe 2/2013

Proposed mechanism of off-target toxicity for antibody–drug conjugates driven by mannose receptor uptake

Boris Gorovits, Corinna Krinos-Fiorotti

01.02.2013 | Original Article | Ausgabe 2/2013

Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer

Stephanie K. Bunt, Ashley M. Mohr, Jennifer M. Bailey, Paul M. Grandgenett, Michael A. Hollingsworth

01.02.2013 | Original article | Ausgabe 2/2013

The antitumor effect of the Toll-like receptor 3 ligand polyinosinic-cytidylic acid as an adjuvant

Yu-Kun Huang, Zhi Zheng, Chun-Xia Cheng, Lu-Ying Wang, Yue-Ran Li, Fu Qiu

01.02.2013 | Original article | Ausgabe 2/2013

T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment

Saskia J. A. M. Santegoets, Anita G. M. Stam, Sinéad M. Lougheed, Helen Gall, Petra E. T. Scholten, Martine Reijm, Karin Jooss, Natalie Sacks, Kristen Hege, Israel Lowy, Jean-Marie Cuillerot, B. Mary E. von Blomberg, Rik J. Scheper, Alfons J. M. van den Eertwegh, Winald R. Gerritsen, Tanja D. de Gruijl

01.02.2013 | Original Article | Ausgabe 2/2013 Open Access

Tumor-specific CD4+ T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells

Ilseyar Akhmetzyanova, Gennadiy Zelinskyy, Simone Schimmer, Sven Brandau, Petra Altenhoff, Tim Sparwasser, Ulf Dittmer

01.02.2013 | Original article | Ausgabe 2/2013

CD40 pathway activation reveals dual function for macrophages in human endometrial cancer cell survival and invasion

Geneviève Dumas, Mathieu Dufresne, Éric Asselin, Julie Girouard, Christian Carrier, Carlos Reyes-Moreno

01.02.2013 | Original article | Ausgabe 2/2013

Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation

Willemijn Hobo, Tatiana I. Novobrantseva, Hanny Fredrix, Jamie Wong, Stuart Milstein, Hila Epstein-Barash, Ju Liu, Nicolaas Schaap, Robbert van der Voort, Harry Dolstra

01.02.2013 | Original Article | Ausgabe 2/2013

Comparative analysis of monocytic and granulocytic myeloid-derived suppressor cell subsets in patients with gastrointestinal malignancies

Austin Duffy, Fei Zhao, Lydia Haile, Jaba Gamrekelashvili, Suzanne Fioravanti, Chi Ma, Tamar Kapanadze, Kathryn Compton, William D. Figg, Tim F. Greten

01.02.2013 | Original article | Ausgabe 2/2013 Open Access

Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation

Katja Hattar, Rajkumar Savai, Florentine S. B. Subtil, Jochen Wilhelm, Anja Schmall, Dagmar S. Lang, Torsten Goldmann, Bastian Eul, Gabriele Dahlem, Ludger Fink, Ralph-Theo Schermuly, Gamal-Andre Banat, Ulf Sibelius, Friedrich Grimminger, Ekkehard Vollmer, Werner Seeger, Ulrich Grandel

01.02.2013 | Original article | Ausgabe 2/2013

Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy

Ashley J. Knights, Jitka Fucikova, Anupama Pasam, Sandra Koernig, Jonathan Cebon

01.02.2013 | Original article | Ausgabe 2/2013

DNA methylation at promoter regions of interleukin 1B, interleukin 6, and interleukin 8 in non-small cell lung cancer

Xavier Tekpli, Nina E. Landvik, Kristine H. Anmarkud, Vidar Skaug, Aage Haugen, Shanbeh Zienolddiny

01.02.2013 | Original article | Ausgabe 2/2013 Open Access

CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells

Masayasu Naito, Ursula Hainz, Ute E. Burkhardt, Buyin Fu, Deborah Ahove, Kristen E. Stevenson, Mohini Rajasagi, Baogong Zhu, Anselmo Alonso, Elizabeth Witten, Ken-ichi Matsuoka, Donna Neuberg, Jonathan S. Duke-Cohan, Catherine J. Wu, Gordon J. Freeman

01.02.2013 | Original article | Ausgabe 2/2013

MHC-class I-restricted CD4 T cells: a nanomolar affinity TCR has improved anti-tumor efficacy in vivo compared to the micromolar wild-type TCR

Carolina M. Soto, Jennifer D. Stone, Adam S. Chervin, Boris Engels, Hans Schreiber, Edward J. Roy, David M. Kranz

01.02.2013 | Original Article | Ausgabe 2/2013

The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigen

Joel F. Aldrich, Michael H. Shearer, Devin B. Lowe, Richard E. Winn, Cynthia A. Jumper, Ronald C. Kennedy, Robert K. Bright

01.02.2013 | Original Article | Ausgabe 2/2013

Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo

Miki Tongu, Nanae Harashima, Hiroyuki Monma, Touko Inao, Takaya Yamada, Hideyuki Kawauchi, Mamoru Harada

01.02.2013 | Original Article | Ausgabe 2/2013

Identification of a novel HLA-A2-restricted mutated Survivin epitope and induction of specific anti-HCC CTLs that could effectively cross-recognize wild-type Survivin antigen

Han Shen, Hong-Wei Shao, Xiao-Hua Chen, Feng-Lin Wu, Hui Wang, Zhao-Liang Huang, Juan Shen, Teng Wang, Wen-Feng Zhang, Shu-Lin Huang

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise